Press Release|

SHL Medical reveals plans to set up manufacturing site in Zug, Switzerland

20201111 1200x630 Zug

Image source: Greater Zurich Area website

SHL Medical (hereinafter referred to as “SHL”) has announced plans to set up a manufacturing site in Zug, Switzerland to support increasing demands for autoinjector production. The new site will enable SHL Medical to address its expanding business needs with the most advanced equipment as well as a more agile set-up and sustainable operations flow.

SHL is a pioneer and technology frontrunner in autoinjectors and advanced drug delivery systems. It employs over 5,200 employees1 worldwide and offers first-in-class design, manufacturing, and final assembly solutions for pharma and biotech clients globally.

In 2018, SHL established its headquarters in Zug to further consolidate its drug delivery offerings and strengthen its partnerships with its global pharmaceutical customers. The new manufacturing site in Europe is an extension of SHL’s ongoing transformation to enhance its business continuity strategy and meet the dynamic growth of market demands.

The SHL facility will be located within the Tech Cluster Zug, which is developed by Metall Zug in collaboration with its subsidiary, Urban Assets Zug AG. The location was selected as it presents an exciting opportunity to set up a smarter and more sustainable building at the outset of the site’s planning. The facility will include both office and production areas, which will be designed to include energy-efficient features and ecologically sustainable manufacturing processes. Construction is expected to be completed in 2026.

“SHL is continuously expanding its footprint to be closer to our customers in the European region as part of our long-term commitment to fortifying our operations in the global landscape. We saw the need to expand our manufacturing capabilities from both a geographical as well as a service perspective, and Zug’s vision to build a smart and ecological technology hub aligns with SHL’s goal to create a more digitalized and sustainable future for the company and its stakeholders,” said SHL Medical CEO, Ulrich Faessler.

Metall Zug is calling for submissions in an architectural competition for the SHL site. Click here to learn more about the project and the Tech Cluster Zug.

1Employment numbers as of October 2020

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News

ZUG, Switzerland, NOV 21, 2024 — SHL Medical, a world leader in self-injection solutions, today announced plans to establish SHL Advantec – a dynamic sub-group dedicated to providing tooling and automation solutions to the healthcare sector and other industries. The establishment of SHL Advantec is part of SHL Medical’s ambitious expansion strategy and ongoing commitment…